Ascent Group LLC Sells 131 Shares of iShares Biotechnology ETF $IBB

Ascent Group LLC decreased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.7% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 4,647 shares of the financial services provider’s stock after selling 131 shares during the quarter. Ascent Group LLC’s holdings in iShares Biotechnology ETF were worth $594,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of IBB. Citigroup Inc. grew its stake in shares of iShares Biotechnology ETF by 88.5% during the first quarter. Citigroup Inc. now owns 3,208,144 shares of the financial services provider’s stock valued at $410,322,000 after buying an additional 1,505,976 shares during the last quarter. Millennium Management LLC boosted its position in iShares Biotechnology ETF by 140.8% in the 1st quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock valued at $5,330,000 after buying an additional 143,893 shares during the period. Jones Financial Companies Lllp boosted its position in iShares Biotechnology ETF by 763.3% in the 1st quarter. Jones Financial Companies Lllp now owns 151,265 shares of the financial services provider’s stock valued at $19,347,000 after buying an additional 133,744 shares during the period. Madrona Financial Services LLC boosted its position in iShares Biotechnology ETF by 153.0% in the 1st quarter. Madrona Financial Services LLC now owns 81,150 shares of the financial services provider’s stock valued at $10,379,000 after buying an additional 49,075 shares during the period. Finally, GAMMA Investing LLC boosted its position in iShares Biotechnology ETF by 12,698.7% in the 1st quarter. GAMMA Investing LLC now owns 48,251 shares of the financial services provider’s stock valued at $6,171,000 after buying an additional 47,874 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $140.65 on Thursday. iShares Biotechnology ETF has a 52-week low of $107.43 and a 52-week high of $150.57. The business’s 50 day moving average is $135.18 and its 200 day moving average is $129.10.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.